đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This is a randomized, two-period, cross-over Phase 2 study, comparing PK, a...
Status
Terminated
Location
The Oncology Institute of Hope & Innovation - Glendale
Start Date
2020-08-04
Trial ID
NCT04412707
Treatments Being Tested
To provide early treatment access and evaluate the safety of melflufen and ...
Status
Approved For Marketing
Location
Highlands Oncology Group
Start Date
TBD
Trial ID
NCT04534322
Treatments Being Tested
Multiple myeloma is the second most common hematologic malignancy in adults...
Status
Recruiting
Location
Praxis fĂŒr interdisziplinĂ€re Onkologie & HĂ€matologie
Start Date
2026-06-01
Trial ID
NCT07559799
This is a phase 1/2 open label study of melphalan flufenamide (melflufen) i...
Status
Terminated
Location
Boston University Medical Center
Start Date
2020-08-06
Trial ID
NCT04115956
Treatments Being Tested
This study will evaluate melflufen in combination with dexamethasone in adu...
Status
Completed
Location
Innovative Clinical Research Institute (ICRI)
Start Date
2016-12-28
Trial ID
NCT02963493
Treatments Being Tested
This is an open-label Phase 1/2a study which will enroll patients that have...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2018-04-12
Trial ID
NCT03481556
Treatments Being Tested
The study will explore escalating doses of melflufen in combination with de...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2013-07
Trial ID
NCT01897714
Treatments Being Tested
This was a multicenter study of the pharmacokinetics (PK) of melphalan duri...
Status
Terminated
Location
University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology
Start Date
2018-08-28
Trial ID
NCT03639610
Treatments Being Tested
This is a pilot study aimed to evaluate the efficacy and tolerability of me...
Status
Withdrawn
Location
A.O.U. delle Marche
Start Date
2025-03-26
Trial ID
NCT06682637
Treatments Being Tested
This was a randomized, controlled, open-label, Phase 3 multicenter study wh...
Status
Terminated
Location
University Multiprofile Hospital for Active Treatment "Sveti Georgi", Plovdiv, Clinical Hematology Clinic
Start Date
2020-12-21
Trial ID
NCT04649060
Treatments Being Tested